Picture of Thermo Fisher Scientific logo

TMO Thermo Fisher Scientific Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Thermo Fisher Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,6966,3757,7286,9605,955
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items-335361,187857882
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-665-395-1,548-1,049-537
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities4,9738,2899,3129,1548,406
Capital Expenditures-926-1,474-2,523-2,243-1,479
Purchase of Fixed Assets
Other Investing Cash Flow Items-561-36-19,40984-3,663
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-1,487-1,510-21,932-2,159-5,142
Financing Cash Flow Items-69-147-91-956
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3,1189596,581-2,810-3,622
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3057,914-5,8454,046-440